(c) 2024 PillSync.com

meclizine hydrochloride tablet

INDICATIONS AND USAGE INDICATIONS Based on a review of this drug by the National Academy of Sciences – National Research Council and/or other information, FDA has classified the indications as follows: Effective: Management of nausea and vomiting, and dizziness associated with motion sickness. Possibly Effective: Management of vertigo associated with diseases affecting the vestibular system. Final classification of the less than effective indications required further investigation.

par pharmaceutical, inc.


6 years ago OVAL YELLOW Par 035 meclizine hydrochloride tablet

OVAL YELLOW Par 035

6 years ago OVAL YELLOW Par 035 meclizine hydrochloride tablet

Par 035 OVAL YELLOW

HOW SUPPLIED Meclizine Hydrochloride Tablets, USP 12.5 mg - blue, oval tablets debossed with “034” on one side and “par” on the other side. Tablets may contain characteristic dye spots. They are supplied in bottles of 100 (NDC 49884-034-01) and 1000 (NDC 49884-034-10). Meclizine Hydrochloride Tablets, USP 25 mg - yellow, oval tablets debossed with “035” on one side and “par” on the other side. They are supplied in bottles of 100 (NDC 49884-035-01) and 1000 (NDC 49884-035-10). Dispense in tight, light-resistant containers as defined in the USP. Store at controlled room temperature 15° to 30°C (59° to 86°F). Manufactured by: PAR PHARMACEUTICAL COMPANIES, INC. Chestnut Ridge, NY 10977 Revised: 07/15 OS034-01-1-15


More pills like OVAL Par 035












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site